cycloastragenol has been researched along with cycloartane in 1 studies
| Studies (cycloastragenol) | Trials (cycloastragenol) | Recent Studies (post-2010) (cycloastragenol) | Studies (cycloartane) | Trials (cycloartane) | Recent Studies (post-2010) (cycloartane) |
|---|---|---|---|---|---|
| 62 | 0 | 55 | 215 | 0 | 147 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akgün, İH; Bedir, E; Debeleç-Bütüner, B; Korkmaz, KS; Öztürk, MB; Tağ, Ö; Yetik-Anacak, G | 1 |
1 other study(ies) available for cycloastragenol and cycloartane
| Article | Year |
|---|---|
Cycloartane-type sapogenol derivatives inhibit NFκB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis.
Topics: Apoptosis; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Chemoprevention; Dinoprostone; Humans; Inflammation; Male; NF-kappa B; Prostatic Neoplasms; Sapogenins; Signal Transduction; Transcription, Genetic; Triterpenes | 2018 |